4titude, Ltd., a manufacturer of scientific consumables for biological sample materials used in a variety of genomic and DNA analytical applications, has been sold to Brooks Automation, Inc. (Nasdaq:BRKS) . Based in Surrey, England, 4titude sells its products into more than 50 countries worldwide.
Founded 12 years ago by industry veterans, 4titude is widely recognized for its innovative PCR plates which are used to “amplify” or copy small segments of DNA, a significant factor in accelerating research. The company also manufactures a range of sealing and sequencing tubes related to bench top instrumentation. 4titude supplies consumable PCR plates to more than 1200 global customers in the pharma, biotech, academic, and biobanking markets.
The total purchase price of the acquisition was approximately $65 million in cash, subject to customary working capital and other adjustments. Over the last two years, 4titude has delivered more than 20% annual growth and generated approximately $14 million of revenue in the last 12 months.
EC M&A acted as exclusive financial advisor to 4titude on this transaction.